Does a preoperative subconjunctival injection of Dexamethason reduce the incidence of proliferative vitreoretinopathy in patients with ablatio retinae?
Completed
- Registration Number
- NL-OMON21185
- Brief Summary
Bali E, Feron EJ, Peperkamp E, Veckeneer M, Mulder PG, van Meurs JC. The effect of a preoperative subconjuntival injection of dexamethasone on blood-retinal barrier breakdown following scleral buckling retinal detachment surgery: a prospective randomized placebo- controlled double blind clinical trial. Graefes Arch Clin Exp Ophthalmol. 2010; 248(7): 957-62. PMID: 20182883
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 40
Inclusion Criteria
1. Primary rhegmatogenous retinal detachment;
2. No previous ablatio surgery.
Exclusion Criteria
1. Diabetes mellitus;
2. Systemic steroids;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of proliferative vitreoretinopathy.
- Secondary Outcome Measures
Name Time Method